Keyphrases
Androgen Receptor
100%
Competitive Inhibitor
100%
Androgen-responsive Gene
100%
Propyl
61%
Carbonitrile
61%
1H-indole
61%
Small Molecules
15%
Receptor-mediated
15%
Prostate-specific Antigen
15%
Prostate Cancer Cells
15%
Receptor Transactivation
15%
Androgen-independent
15%
Regulated Genes
7%
LNCaP Cells
7%
Site of Action
7%
Androgens
7%
Prostate Cancer
7%
Chromatin Immunoprecipitation (ChIP)
7%
Gene Activation
7%
High-throughput Screening
7%
Luciferase Reporter
7%
New Therapeutics
7%
Stably Expressing
7%
Steroid Receptors
7%
Agonist Activity
7%
Nuclear Localization
7%
Anchorage-independent Growth
7%
Luciferase
7%
Novel Inhibitors
7%
Prostate Cancer Cell Lines
7%
Castration-resistant Prostate Cancer
7%
Bicalutamide
7%
T877A
7%
Therapeutic Inhibitors
7%
Medicine and Dentistry
Competitive Inhibition
100%
Androgen Receptor
100%
Androgen
100%
Prostate Cancer
23%
Cancer Cell
15%
Luciferase
15%
Prostate Specific Antigen
15%
Transactivation
15%
Cell Line
7%
Promoter Region
7%
Gene Activation
7%
Enhancer Region
7%
Castration Resistant Prostate Cancer
7%
Chromatin Immunoprecipitation
7%
Steroid Receptor
7%
Bicalutamide
7%
Prostate Cancer Cell Line
7%
Anchorage Independent Growth
7%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen
100%
Competitive Inhibitor
100%
Androgen Receptor
100%
Indole
61%
Prostate Cancer
30%
Luciferase
15%
Prostate Specific Antigen
15%
Chromatin Immunoprecipitation
7%
Castration Resistant Prostate Cancer
7%
Steroid Receptor
7%
Bicalutamide
7%